Under Vioxx Fire, Merck Faces Fosamax Claims Too
With trials over the potential side effects of Merck & Co.'s former blockbuster Vioxx underway, the pharmaceutical giant may soon be headed to court on charges related to its second-biggest seller,...To view the full article, register now.
Already a subscriber? Click here to view full article